APLS
Apellis Pharmaceuticals Inc
3.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
Apellis Pharmaceuticals Inc (APLS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -61 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -150 | -169 | -98 | -133 | -8.3 | 34 | 19 | -53 | 4.4 | 108 | -14 | -61 | 38 | |
| 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | 0.3 | -1.2 | 0.3 | -0.2 | |
| 29 | 22 | 26 | 30 | 30 | 27 | 26 | 27 | 27 | 28 | -83 | 25 | -2.2 | |
| 36 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -64 | -57 | -43 | -103 | -6.2 | 63 | 28 | 10 | 18 | -136 | 23 | -106 | -201 | |
| 0.4 | 0.0 | 0.1 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.0 | 0.4 | |
| -0.4 | 0.0 | 0.0 | -0.3 | -0.1 | – | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 | – | – | |
| 1.6 | – | 1.6 | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | 3.2 | – | – | 2.2 | – | -2.2 | – | – | |
| – | – | – | – | – | 0.0 | 0.0 | – | – | 0.0 | 0.0 | – | – | |
| 1.6 | 5.7 | -3.9 | 108 | 42 | 2.5 | -4.0 | 0.3 | 6.6 | 0.8 | 1.3 | 0.1 | 8.7 | |
| -149 | -164 | -101 | -25 | 34 | 37 | 14 | -53 | 12 | 109 | -13 | -61 | 47 | |
| -151 | -169 | -98 | -133 | -8.4 | 34 | 19 | -53 | 4.4 | 108 | -14 | -61 | 38 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.